Instead, we employed a NF-κB-mediated dermatitis, because we did not have a model of pancreatitis, and we wished to investigate whether GGT1-mediated NF-κB activation plays a role in the development of inflammatory diseases in vivo via the IL-6 amplifier activation. This evidence concerns the gene NFKB1 and skin disorder.